Candel Therapeutics Inc (CADL)
SG&A Expense Growth
7.77%
Quarterly · Period ending:
CADL SG&A Expense Growth
Latest reported7.77%period ending
Latest reported7.77%period ending
CADL Quarterly SG&A Growth (QoQ) (0.00% → 7.77%)
Latest values, visible window
High-resolution chart · PNG
CADL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.7747% | |
| 36.4098% | |
| -0.4635% | |
| 13.3779% | |
| 1.7501% | |
| 23.7665% | |
| -0.5088% | |
| -6.9878% | |
| -5.4737% | |
| 24.183% | |
| 1.4589% | |
| -17.2565% | |
| -12.464% | |
| 31.7722% | |
| -10.6335% | |
| -6.0074% | |
| 4.5% | |
| -8.0929% | |
| 40.1431% | |
| 37.0098% | |
| 5.4264% | |
| -43.6517% | |
| 255.1189% | |
| 13.0994% | |
| 17.4451% | |
| 0% |